Language selection

Search

Patent 2731454 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2731454
(54) English Title: A HERBAL AND VITAMIN C COMPOSITION USED FOR TREATING INFLAMMATION AND THE MAINENANCE OF GOOD HEALTH
(54) French Title: COMPOSITION A BASE DE PLANTES MEDICINALES ET DE VITAMINE C UTILISEE POUR LE TRAITEMENT DE L'INFLAMMATION ET LE MAINTIEN DE LA SANTE
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61K 36/9066 (2006.01)
  • A61K 31/375 (2006.01)
  • A61K 36/54 (2006.01)
  • A61K 36/61 (2006.01)
  • A61K 36/81 (2006.01)
  • A61K 36/8962 (2006.01)
  • A61K 36/906 (2006.01)
  • A61P 19/02 (2006.01)
  • A61P 29/00 (2006.01)
(72) Inventors :
  • LEBLANC, RUSSELL (Canada)
(73) Owners :
  • RUSSELL LEBLANC
(71) Applicants :
  • RUSSELL LEBLANC (Canada)
(74) Agent:
(74) Associate agent:
(45) Issued:
(22) Filed Date: 2011-02-10
(41) Open to Public Inspection: 2012-08-10
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract


A herbal medicinal and vitamin C composition for treating joint pain due to
inflammation, maintaining cardiovascular health in adults, helping reduce
elevated blood lipids/hyperlipidemia in adults, helping relieve bronchitis,
coughs and colds, helping the body metabolize fats and proteins and helping
support peripheral circulation.


Claims

Note: Claims are shown in the official language in which they were submitted.


The embodiment of the invention in which an exclusive property or privilege is
claimed are defined as follows:
1) A composition of cayenne, cinnamon, clove, garlic, ginger, turmeric and
vitamin C, whereas the mixture the mixture is used in the treatment of joint
pain
due to inflammation, in the maintenance of good health, in maintaining
cardiovascular
health in adults, helping reduce elevated blood lipids in adults, helping
relieve
bronchitis, coughs and colds, helping the body metabolize fats and proteins
and
helping support peripheral circulation.
2) The composition according to claim 1, whereas the minimal amount of
cayenne is 90 mg and the maximum amount of cayenne is 360 mg.
3) The composition according to claim 1, whereas the minimal amount of
cinnamon is 1000 mg and the maximum amount of cinnamon is 2500 mg.
4) The composition according to claim 1, whereas the minimal amount of clove
is 400 mg and the maximum amount of clove is 750 mg.
5) The composition according to claim 1, whereas the minimal amount of garlic
is 500 mg and the maximum amount of garlic is 12,000 mg.
6) The composition according to claim 1, whereas the minimal amount of
ginger is 600 mg and the maximum amount of ginger is 3000 mg.
7) The composition according to claim 1, whereas the minimal amount of
turmeric is 1000 mg and the maximum amount of turmeric is 4000 mg.
8) The composition according to claim 1, whereas the minimal amount of
vitamin C is 2.2 mg and the maximum amount of the vitamin C is 2000 mg.
9) The composition according to claims 1 and 3, the cinnamon is true
cinnamon.
6

10) The composition according to claims 1 and 3, the cinnamon is cassia
cinnamon.
11) The composition according to claims 1 and 3, the cinnamon is a blend of
true and cassia cinnamon.
12) The composition according to claim 1, the cayenne, cinnamon, clove,
garlic, ginger and turmeric are organically grown.
7

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02731454 2011-02-10
A HERBAL AND VITAMIN C COMPOSITION USED FOR TREATING
INFLAMMATION AND THE MAINTENANCE OF GOOD HEALTHh
Field Of Search:
U.S. Patent 7,396,546 July 8, 2008 Rosenbloom, Richard A.
U.S. Patent 6,841,544 January 11, 2005 Gelber et al
U.S. Patent 6,827,945 December 7, 2004 Rosenbloom, Richard A.
U.S. Patent 6,596,313 July 22, 2003 Rosenbloom
U.S. Patent 6,391,346 May 21, 2002 Newmark, et al
U.S. Patent 6,030,980 February 29, 2002 Suzuki
U.S. Patent 5,976,568 November 2, 1999 Riley
U.S. Patent 5,908,857 June 1, 1999 Suzuki
U.S. Patent 5,891,924 April 6, 1999 Aggarwal, Bharat B.
U.S. Patent 5,643,623 July 1, 1997 Schlnitz, Harold H.
U.S. Patent 5,137,922 August 11, 1992 Shimamura, et al
References
Bradley PR, editor, British Herbal Compendium: A Handbook of Scientific
Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK):
British Herbal Association; 2006
Kojuri J. et al- 2007. Effects of anethum graveolens and garlic on lipid
profile
in hyperlipidemic patients. Lipids in Health and Disease 6(5) : 1476-1511
Mills S, Bone K. 2000. Principles and Practice of Phytotherapy. Toronto (On):
Churchill Livingstone.
1

CA 02731454 2011-02-10
Wren RCC. 1907. Potter's cyclopedia of Botanical Drugs and Preparations.
London (GB): Potter and Clark
Bradley PR, editor, 1992. British Herbal Compendium
Blumenthal M, Goldberg A, Brinkmann J, editors. 2000. Herbal Medicine:
Expanded Commission E monographs, Boston (MA); Integrative Medicine
Communications
Mills S, Bone K, 2005. The Essential Guide to Herbal Safety. St Louis (MO) :
Elsevier Churchill Livingstone
Groff J, Gropper S. Advanced Nutrition and Human Metabolism, 3( edition,
Belmont (CA): Wadsworth/Thomson learning: 2000
SPECIFICATION
1. Field of the Invention
This invention relates to a herbal medicinal and vitamin C composition used in
the treatment of inflammation and the maintenance of good health.
2. Description of the Prior Art
It is desirable to manufacture a medicinal composition that helps treat
multiple
health issues such as joint pain due to inflammation, elevated blood lipids
levels, relieve symptoms of bronchitis, coughs and colds as well as helping
support peripheral circulation.
Currently, herbal medicines focus on limited health issues and therefore
multiple herbal remedies are required in order to have the same effectiveness
of
the present invention. Therefore, the consumer will save money by purchasing
the present invention as opposed to purchasing a combination of herbal
medicines in order to have the equivalent efficacy of the present invention.
OBJECTS OF THE INVENTION
It is an object of this invention to provide a herbal medicinal and vitamin C
composition that is suitable for treating joint pain due to inflammation,
suitable
2

CA 02731454 2011-02-10
for maintaining cardiovascular health in adults, suitable for helping reduce
elevated blood lipid/hyperlipidemia in adults, suitable in helping relieve
bronchitis, coughs and colds and suitable in helping the body metabolize fats
and proteins.
This and further objects of this invention will become more apparent as the
description of the invention proceeds.
SUMMARY OF THE INVENTION
The foregoing and further objects and advantages are obtained by
manufacturing a herbal medicinal composition combined with vitamin C. The
combined medicinal herbs and vitamin C encapsulated using conventional
capsule assembly equipment.
BRIEF DESCRIPTION OF THE DRAWINGS
In the accompany drawings
FIG. I illustrates a cross-sectional top view of a capsule containing the
invention
FIG. 2 illustrates a cross-sectional view of a whole capsule containing the
invention
DESCRIPTION OF THE PREFERRED EMBODIMENTS
The current invention achieves the desired results by combining specific herbs
with vitamin C also known as ascorbic acid. The herbs may be organically or
3

CA 02731454 2011-02-10
in-organically grown. However the preferred embodiment uses organically
grown herbs.
The herbs used in the present invention are: cayenne, cinnamon, garlic,
ginger,
cloves and turmeric. Pure cinnamon may be used or cassia cinnamon may also
be used or a combination thereof. The cinnamon used in the preferred
embodiment is sweet or pure cinnamon. All the herbs used in the invention will
be in powdered form. The specific herbs are mixed with a pre-determined
amount of vitamin C.
Using conventional capsule filling equipment, a pre-determined amount of the
mixed herbs and vitamin C is placed in a gelatin based or vegetable based
capsule, the preferred capsule type being vegetable based.
Each capsule is tapped at least once and refilled accordingly. The capsule cap
is
then inserted in the capsule body completing the capsule.
The finished capsule containing the six herbs and the vitamin C is then
polished
and bottled accordingly.
Figure 1 (1) illustrates the capsule outline of a top view cross-section of a
filled
capsule, Fig. 1 (2) illustrates vitamin C and Fig. 1 (3) illustrates medicinal
herbs.
Figure 2 (4) illustrates herbal medicine in a cross-sectional view of a whole
capsule containing the invention, Fig.2 (5) illustrates the capsule body in a
cross-sectional view of a whole capsule containing the invention and Fig. 3
(6)
Illustrates vitamin C in a cross-sectional view of a whole capsule containing
the
Invention.
The minimum and maximum amount of each herb is shown below:
Minimum Maximum
Cayenne 90 mg 360 mg
Cinnamon 1000 mg 2500 mg
Cloves 400 mg 750 mg
Garlic 500 mg 12000 mg
Ginger 600 mg 3000 mg
Turmeric 1000 mg 4000 mg
The minimum and maximum daily amount of vitamin C is shown
below:
4

CA 02731454 2011-02-10
Minimum Maximum
Vitamin C 2.2 mg 2000 mg
The preferred embodiment will have the following daily amounts:
Cayenne 261 mg
Cinnamon 1008 mg
Cloves 450 mg
Garlic 792 mg
Ginger 783 mg
Turmeric 1008 mg
Vitamin C 477 mg
It was found that if the preferred daily dosage of the present invention is
encapsulated in 00 type capsules, 9 capsules are required. The recommended
capsule amount per meal was found to be three and to be taken three times a
day.

Representative Drawing

Sorry, the representative drawing for patent document number 2731454 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Application Not Reinstated by Deadline 2014-02-11
Time Limit for Reversal Expired 2014-02-11
Letter Sent 2013-12-09
Inactive: Protest acknowledged 2013-12-09
Inactive: Protest/prior art received 2013-12-03
Inactive: Adhoc Request Documented 2013-11-14
Inactive: Adhoc Request Documented 2013-11-01
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2013-02-11
Application Published (Open to Public Inspection) 2012-08-10
Inactive: Cover page published 2012-08-09
Inactive: IPC assigned 2011-03-10
Inactive: IPC assigned 2011-03-10
Inactive: IPC assigned 2011-03-10
Inactive: IPC assigned 2011-03-10
Inactive: IPC assigned 2011-03-10
Inactive: IPC assigned 2011-03-10
Inactive: IPC assigned 2011-03-10
Inactive: IPC assigned 2011-03-10
Inactive: IPC assigned 2011-03-10
Inactive: First IPC assigned 2011-03-10
Inactive: Office letter 2011-03-01
Inactive: Filing certificate - No RFE (English) 2011-03-01
Application Received - Regular National 2011-03-01
Small Entity Declaration Determined Compliant 2011-02-10

Abandonment History

Abandonment Date Reason Reinstatement Date
2013-02-11

Fee History

Fee Type Anniversary Year Due Date Paid Date
Application fee - small 2011-02-10
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
RUSSELL LEBLANC
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 2011-02-09 1 15
Description 2011-02-09 5 172
Claims 2011-02-09 2 54
Drawings 2011-02-09 1 11
Filing Certificate (English) 2011-02-28 1 157
Notice: Maintenance Fee Reminder 2012-11-13 1 119
Courtesy - Abandonment Letter (Maintenance Fee) 2013-04-07 1 172
Second Notice: Maintenance Fee Reminder 2013-08-12 1 119
Notice: Maintenance Fee Reminder 2013-11-12 1 120
Correspondence 2011-02-28 1 26